









Markets
/
Stocks
/
nasdaq-vsee
/

Vsee Health Inc

VSEE

1.010USD

-0.010-0.98%

Close 11/05, 16:00（ET）Quotes delayed by 15 min

16.59MMarket Cap

LossP/E TTM



Vsee Health Inc

1.010

-0.010-0.98%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Vsee Health Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively weak. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a . Despite a strong stock market performance and outperforming fundamentals, the technicals don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Vsee Health Inc's Score

Industry at a Glance

Industry Ranking

255 / 485

Overall Ranking

481 / 4616

Industry

Software & IT Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

5.000

Target Price

+278.79%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Vsee Health Inc Highlights

StrengthsRisks

VSee Health, Inc. operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. VSee provides patient engagement solutions, clinician staffing solutions, remote physical exam and remote patient monitoring solutions, and AI for telesitter and telenursing solutions. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. iDoc is a provider of teleneurointensivists for neuro-critical care.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 63.40% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 10.42M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 10.42M.

Overvalued

The company’s latest PE is -0.17, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 1.34M shares, increasing 7.58% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 9.79K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 6.62, which is lower than the Software & IT Services industry's average of 7.26. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 3.39M, representing a year-over-year increase of 98.07%, while its net profit experienced a year-over-year increase of 691.95%.

Score

Industry at a Glance

Previous score

6.62

Change



Financials

3.92

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.55

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

4.09

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.55

Key Metrics

Free cash flow

No Data

Vsee Health Inc's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 6.80, which is lower than the Software & IT Services industry's average of 7.30. Its current P/E ratio is -0.17, which is -100.00% below the recent high of 0.00 and -122635.33% above the recent low of -210.86.

Score

Industry at a Glance

Previous score

6.80

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 255/485

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

There is no earnings forecast score for this company; the Software & IT Services industry's average is 7.59. The average price target for Vsee Health Inc is 5.00, with a high of 5.00 and a low of 5.00.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 3.86, which is lower than the Software & IT Services industry's average of 6.56. Sideways: Currently, the stock price is trading between the resistance level at 2.21 and the support level at 0.14, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

3.84

Change

0.02

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.067

Buy

RSI(14)

57.102

Neutral

STOCH(KDJ)(9,3,3)

23.606

Neutral

ATR(14)

0.326

High Vlolatility

CCI(14)

28.142

Neutral

Williams %R

73.127

Sell

TRIX(12,20)

2.297

Buy

StochRSI(14)

13.399

Oversold

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

1.029

Sell

MA10

0.949

Buy

MA20

0.792

Buy

MA50

0.718

Buy

MA100

0.933

Buy

MA200

1.126

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-04

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Aisiku (Imoigele)

3.26M

-4.69%

Chen (Milton)

2.84M

-1.00%

Digital Health Sponsor LLC

2.83M

+7.65%

SCS Capital Management LLC

500.00K

Wickersham (David L.)

214.00K

+87.72%

Geode Capital Management, L.L.C.

78.10K

+2.16%

UBS Financial Services, Inc.

52.51K

-41.75%

Osaic Holdings, Inc.

45.17K

+197.46%

State Street Investment Management (US)

18.90K

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 1.55, which is lower than the Software & IT Services industry's average of 4.86. The company's beta value is 0.45. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.